Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.

Yutaka Isozaki; Norimasa Yoshida; Masaaki Kuroda; Osamu Handa; Tomohisa Takagi; Satoshi Kokura; Hiroshi Ichikawa; Yuji Naito; Takesi Okanoue; Toshikazu Yoshikawa

doi:10.1080/00365520500529470

Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.

Identifier:nobleid.org/w1/20260515/2BC64C85

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2BC64C85.svg?ark=w1%2F20260515%2F2BC64C85)](https://nobleid.org/work/w1/20260515/2BC64C85)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.

Identifier:nobleid.org/w1/20260515/2BC64C85

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2BC64C85.svg?ark=w1%2F20260515%2F2BC64C85)](https://nobleid.org/work/w1/20260515/2BC64C85)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work